Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms DOI Creative Commons

Dandan Li,

Lingyun Xia,

Pan Huang

et al.

Cell Proliferation, Journal Year: 2023, Volume and Issue: 56(6)

Published: Feb. 19, 2023

Epithelial-mesenchymal transition (EMT) or mesenchymal-epithelial (MET) plays critical roles in cancer metastasis. Recent studies, especially those based on single-cell sequencing, have revealed that EMT is not a binary process, but heterogeneous and dynamic disposition with intermediary partial states. Multiple double-negative feedback loops involved by EMT-related transcription factors (EMT-TFs) been identified. These between drivers MET finely regulate the state of cell. In this review, general characteristics, biomarkers molecular mechanisms different states were summarized. We additionally discussed direct indirect tumour More importantly, article provides evidence heterogeneity closely related to poor prognosis gastric cancer. Notably, seesaw model was proposed explain how cells themselves remain specific states, including epithelial state, hybrid/intermediate mesenchymal state. Additionally, also review current status, limitations future perspectives signalling clinical applications.

Language: Английский

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth DOI Creative Commons
Karin E. de Visser, Johanna A. Joyce

Cancer Cell, Journal Year: 2023, Volume and Issue: 41(3), P. 374 - 403

Published: March 1, 2023

Language: Английский

Citations

1658

Genetics and biology of prostate cancer DOI Open Access
Guocan Wang, Di Zhao, Denise J. Spring

et al.

Genes & Development, Journal Year: 2018, Volume and Issue: 32(17-18), P. 1105 - 1140

Published: Sept. 1, 2018

Despite the high long-term survival in localized prostate cancer, metastatic cancer remains largely incurable even after intensive multimodal therapy. The lethality of advanced disease is driven by lack therapeutic regimens capable generating durable responses setting extreme tumor heterogeneity on genetic and cell biological levels. Here, we review available model systems, genome atlas, cellular functional microenvironment, tumor-intrinsic tumor-extrinsic mechanisms underlying resistance, technological advances focused detection management. These advances, along with an improved understanding adaptive to conventional therapies, anti-androgen therapy, immunotherapy, are catalyzing development more effective strategies for disease. In particular, knowledge heterotypic interactions between coevolution host cells microenvironment has illuminated novel combinations a strong potential eventual cures Improved management will also benefit from artificial intelligence-based expert decision support systems proper standard care, prognostic determinant biomarkers minimize overtreatment disease, new standards care accelerated next-generation clinical trials.

Language: Английский

Citations

643

Circulating tumor cells: biology and clinical significance DOI Creative Commons

Danfeng Lin,

Lesang Shen,

Meng Luo

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2021, Volume and Issue: 6(1)

Published: Nov. 22, 2021

Abstract Circulating tumor cells (CTCs) are that have sloughed off the primary and extravasate into circulate in blood. Understanding of metastatic cascade CTCs has tremendous potential for identification targets against cancer metastasis. Detecting these very rare among massive blood is challenging. However, emerging technologies detection profoundly contributed to deepening investigation biology facilitated their clinical application. Current summarized herein, together with advantages disadvantages. The usually dependent on molecular markers, epithelial cell adhesion molecule being most widely used, although markers vary between different types cancer. Properties associated epithelial-to-mesenchymal transition stemness been identified CTCs, indicating increased capacity. Only a small proportion can survive eventually initiate metastases, suggesting an interaction modulation hostile microenvironment essential CTC Single-cell sequencing extensively investigated, enabled researchers reveal genome transcriptome CTCs. Herein, we also review applications especially monitoring response treatment evaluating prognosis. Hence, will continue contribute providing significant insights processes open new avenues useful applications.

Language: Английский

Citations

634

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis DOI Creative Commons

Yuhe Huang,

Weiqi Hong,

Xiawei Wei

et al.

Journal of Hematology & Oncology, Journal Year: 2022, Volume and Issue: 15(1)

Published: Sept. 8, 2022

Abstract Epithelial–mesenchymal transition (EMT) is an essential process in normal embryonic development and tissue regeneration. However, aberrant reactivation of EMT associated with malignant properties tumor cells during cancer progression metastasis, including promoted migration invasiveness, increased stemness, enhanced resistance to chemotherapy immunotherapy. tightly regulated by a complex network which orchestrated several intrinsic extrinsic factors, multiple transcription post-translational control, epigenetic modifications, noncoding RNA-mediated regulation. In this review, we described the molecular mechanisms, signaling pathways, stages tumorigenesis involved discussed dynamic non-binary its role metastasis. Finally, summarized challenges immunotherapy proposed strategies for therapy targeting EMT.

Language: Английский

Citations

503

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities DOI
Chen Hu, Jing Yang,

Ziping Qi

et al.

MedComm, Journal Year: 2022, Volume and Issue: 3(3)

Published: Aug. 2, 2022

The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both prokaryotic eukaryotic organisms, they maintain cellular proteostasis protect cells from stresses. HSP classified based on their molecular weights, mainly including large HSPs, HSP90, HSP70, HSP60, HSP40, small HSPs. They function as chaperons work an integrated network, participating the folding of newly synthesized polypeptides, refolding metastable proteins, complex assembly, dissociating aggregate dissociation, degradation misfolded proteins. In addition to chaperone functions, also play important roles cell signaling transduction, cycle, apoptosis regulation. Therefore, malfunction HSPs is related with many diseases, cancers, neurodegeneration, other diseases. this review, we describe current understandings about mechanisms major HSP90/HSP70/HSP60/HSP110 how keep response stresses, discuss diseases recent exploration therapy diagnosis modulate These research advances offer new prospects potential targets for therapeutic intervention.

Language: Английский

Citations

373

The Hippo signalling pathway and its implications in human health and diseases DOI Creative Commons

Minyang Fu,

Yuan Hu,

Tianxia Lan

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: Nov. 8, 2022

Abstract As an evolutionarily conserved signalling network, the Hippo pathway plays a crucial role in regulation of numerous biological processes. Thus, substantial efforts have been made to understand upstream signals that influence activity pathway, as well its physiological functions, such cell proliferation and differentiation, organ growth, embryogenesis, tissue regeneration/wound healing. However, dysregulation can cause variety diseases, including cancer, eye cardiac pulmonary renal hepatic immune dysfunction. Therefore, therapeutic strategies target dysregulated components might be promising approaches for treatment wide spectrum diseases. Here, we review key critical functions controlled by pathway. Additionally, diseases associated with alterations potential therapies targeting will discussed.

Language: Английский

Citations

337

The roles of tumor-associated macrophages in tumor angiogenesis and metastasis DOI
Luo‐Qin Fu,

Wenlin Du,

Mao-Hua Cai

et al.

Cellular Immunology, Journal Year: 2020, Volume and Issue: 353, P. 104119 - 104119

Published: May 4, 2020

Language: Английский

Citations

328

Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion DOI
Yuanyuan Jiang, Hanxiang Zhan

Cancer Letters, Journal Year: 2019, Volume and Issue: 468, P. 72 - 81

Published: Oct. 9, 2019

Language: Английский

Citations

272

Tumor microenvironment differences between primary tumor and brain metastases DOI Creative Commons
Bernardo Cacho‐Díaz,

Donovan R. García-Botello,

Talía Wegman-Ostrosky

et al.

Journal of Translational Medicine, Journal Year: 2020, Volume and Issue: 18(1)

Published: Jan. 3, 2020

Abstract The present review aimed to discuss contemporary scientific literature involving differences between the tumor microenvironment (TME) in melanoma, lung cancer, and breast cancer their primary site TME brain metastases (BM). plays a fundamental role behavior of cancer. In process carcinogenesis, cells such as fibroblasts, macrophages, endothelial cells, natural killer other can perpetuate progress carcinogenesis via secretion molecules. Oxygen concentration, growth factors, receptors initiate angiogenesis are examples importance microenvironmental conditions performance neoplastic cells. most frequent malignant tumors metastatic origin primarily originate from melanoma. Metastatic have adhere penetrate blood–brain barrier (BBB). After traversing BBB, these survive by producing various cytokines, chemokines, mediators modify new TME. is currently being studied owing discovery therapeutic targets. three types tumors, treatment more effective than BM due several including BBB. Understanding characteristics surrounding respective metastasis might help improve strategies comprehend

Language: Английский

Citations

252

EMT‐associated microRNAs and their roles in cancer stemness and drug resistance DOI Creative Commons
Guangtao Pan, Yuhan Liu,

Luorui Shang

et al.

Cancer Communications, Journal Year: 2021, Volume and Issue: 41(3), P. 199 - 217

Published: Jan. 27, 2021

Abstract Epithelial‐to‐mesenchymal transition (EMT) is implicated in a wide array of malignant behaviors cancers, including proliferation, invasion, and metastasis. Most notably, previou studies have indicated that both cancer stem‐like properties drug resistance were associated with EMT. Furthermore, microRNAs (miRNAs) play pivotal role the regulation EMT phenotype, as result, some miRNAs impact stemness resistance. Therefore, understanding relationship between EMT‐associated stemness/drug beneficial to basic research clinical treatment. In this review, we preliminarily looked into various roles nature cells. Then, reviewed interaction drug‐resistant complex signaling pathways multiple cancers lung cancer, gastric gynecologic breast liver colorectal pancreatic esophageal nasopharyngeal cancer. We finally discussed EMT, stemness, resistance, well forward potential applications miRNA therapy for tumors.

Language: Английский

Citations

246